borderline significanceP = 0.054
We found the rs3200401 CT + TT genotype was associated with a decreased death risk at a borderline significance among lung adenocarcinoma patients with age ≤ 65 [HR (95% CI) = 0.59 (0.35–1.00), P = 0.054]) and stage IIIA-IIIB [HR (95% CI) = 0.54 (0.29–1.01), P = 0.053].